Home / News Center / Policy & Regulation
News Center · Policy & RegulationNew ingredient filings hit a record high: New dividends from shifting channels
New ingredient filings hit a record high has been gaining momentum. Data shows that in Q2, top-brand concentration rose to 15.8%, and industry attention is clearly rising. This piece breaks down new dividends from shifting channels using public information and platform data.
Competitively, moves by leaders such as HBN are a bellwether. Performance in Guangzhou deserves particular attention, as shifts in channel and audience structure are reshaping growth logic.
Two signals stand out from HBN’s latest moves: resources keep concentrating at the top, while incremental markets like Guangzhou gain bargaining power.
| Metric | Value | Note |
|---|---|---|
| Core metric | 15.8% | Q2 data |
| Brand to watch | HBN | Guangzhou market |
| Outlook | Structural upcycle | New dividends from shifting channels |
For practitioners, three directions follow: differentiate product and content back to R&D and supply chain; build localisation capability for markets such as Guangzhou; and treat compliance and data capability as the new moat.
Bottom line: new ingredient filings hit a record high is moving from concept to execution — new dividends from shifting channels. Brands should review strategy before Q2 and prioritise channels and segments with higher certainty.
Related
Regulatory View: Compliance Paths and Standards for Soluble Microcrystal Patches
Dissolving microneedle products face a dual regulatory path of cosmetics versus medical devices:…
E-commerce sampling compliance rate rises: Where the next growth curve lies
E-commerce sampling compliance rate rises has been gaining momentum. Data shows that in Q4, onli…
Children’s cosmetics rules tighten further: Reading competitive dynamics from the supply side
Children’s cosmetics rules tighten further has been gaining momentum. Data shows that in Q3, new…
Efficacy claim evaluation rules take effect: A breakout playbook for smaller brands
Efficacy claim evaluation rules take effect has been gaining momentum. Data shows that in Q1, ma…